300
Participants
Start Date
November 17, 2024
Primary Completion Date
July 31, 2029
Study Completion Date
July 31, 2030
Teclistamab Monotherapy
standard of care
Teclistamab
investigational doses compared to SOC
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Mt. Sinai School of Medicine, New York
RECRUITING
Atrium Levine Cancer Institute, Charlotte
RECRUITING
Emory Winship Cancer Center, Atlanta
RECRUITING
Tennessee Oncology, Nashville
RECRUITING
Barbara Ann Karmanos Cancer Center, Detroit
NOT_YET_RECRUITING
Mayo Clinic Rochester, Rochester
RECRUITING
University of Chicago Cancer Center, Chicago
RECRUITING
Washington University Medicine, St Louis
RECRUITING
City of Hope, Duarte
RECRUITING
Beth Israel Deaconess Medical Center, Boston
RECRUITING
Dana Farber Cancer Institute/Harvard Medical School, Boston
RECRUITING
Hackensack University Medical Center, Hackensack
Multiple Myeloma Research Consortium
NETWORK